Jan S. Moreb
Impact in
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Oncology top 2%
- Cancer Cells and Metastasis
- Bone health and treatments
Papers in
- Hematology 66
- Hematopoietic Stem Cell Transplantation 30
- Multiple Myeloma Research and Treatments 29
- Acute Myeloid Leukemia Research 10
- Oncology 56
- Cancer Treatment and Pharmacology 11
- Bone health and treatments 8
- Co-authors
- James R. ZucaliBlanca OstmarkJohn R. WingardShahab KhanKlaus PorsLung‐Ji ChangCraig S. KitchensDeniz A. Uçar
- Journals
- Blood (8 papers)Cancer (6 papers)Biology of Blood and Marrow Transplantation (5 papers)Bone Marrow Transplantation (4 papers)Cancer Chemotherapy and Pharmacology (3 papers)
- Partner nations
- United StatesIsraelHungary
In The Last Decade
Jan S. Moreb
122 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 113
- Hematology 926
- Oncology 1.6k
- Cancer Research 628
- Genetics 302
- Orthopedics and Sports Medicine 191
Countries citing papers authored by Jan S. Moreb
This map shows the geographic impact of Jan S. Moreb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan S. Moreb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan S. Moreb more than expected).
Fields of papers citing papers by Jan S. Moreb
This network shows the impact of papers produced by Jan S. Moreb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan S. Moreb. The network helps show where Jan S. Moreb may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan S. Moreb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 20 | |
| 2 | 2018 | 68 | |
| 3 | 2017 | 1 | |
| 4 | 2017 | 1 | |
| 5 | 2017 | 10 | |
| 6 | 2017 | 20 | |
| 7 | 2015 | 26 | |
| 8 | 2014 | 88 | |
| 9 | 2012 | 9 | |
| 10 | 2008 | 11 | |
| 11 | 2008 | 132 | |
| 12 | ALDH isozymes downregulation effects on cell growth and gene expression in lung cancer cell lines | 2007 | 14 |
| 13 | 2003 | 29 | |
| 14 | 2003 | 79 | |
| 15 | 2002 | 12 | |
| 16 | 2001 | 13 | |
| 17 | 1998 | 16 | |
| 18 | 1998 | 29 | |
| 19 | 1995 | 6 | |
| 20 | 1989 | 8 |
About Jan S. Moreb
Jan S. Moreb is a scholar working on Hematology, Oncology, Genetics, Cancer Research and Orthopedics and Sports Medicine, having authored 123 papers that have together received 3.3k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (30 papers), Multiple Myeloma Research and Treatments (29 papers), Cancer Treatment and Pharmacology (11 papers), Acute Myeloid Leukemia Research (10 papers), Cancer, Hypoxia, and Metabolism (10 papers), Bone health and treatments (8 papers), Immune Cell Function and Interaction (8 papers) and Protein Degradation and Inhibitors (8 papers). The work is most often cited by research in Hematology (926 citations), Oncology (1.6k citations), Cancer Research (628 citations), Genetics (302 citations) and Orthopedics and Sports Medicine (191 citations). Jan S. Moreb has collaborated with scholars based in United States, Israel and Hungary. Frequent co-authors include James R. Zucali, Blanca Ostmark, John R. Wingard, Shahab Khan, Klaus Pors, Lung‐Ji Chang, Craig S. Kitchens, Deniz A. Uçar, Christopher R. Cogle and Michele W. Sugrue. Their work appears in journals such as Blood, Cancer, Biology of Blood and Marrow Transplantation, Bone Marrow Transplantation and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.